HF Recommendations and Guidelines
Clinical Guidelines
Three national professional organizations have issued guidelines (4, 5) for the care of patients with heart failure. These documents are firmly grounded in clinical trial
evidence such as those described above, are consistent with respect to their recommendations for use of pharmacological agents for treating heart failure, and
represent the consensus of experts in the United States. The process objectives for the National Heart Failure Project are therefore derived directly from these
guidelines. The guidelines contain additional treatment recommendations (e.g. beta-blockers) beyond the use of ACE inhibitors. Only those recommendations adaptable to the inpatient venue were translated into CMS quality indicators. These indicators are not guidelines, but are intended to measure health care performance.
4. Heart Failure Society of America. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunctionpharmacological approaches. J Cardiac Failure 1999; 5:357-382.
5. Hunt S, Baker D, Chin M, Cinquegrani M, Feldman A, Francis GS et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure
in the adult: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the
1995 Guidelines for the Evaluation and Management of Heart Failure). www.acc.org/clinical/guidelines/failure/hf_index.htm (2001)
If you have a disability and need a document on this Web site to be provided to you in another format, please contact the Webmaster.
|
|
